Obexelimab met the primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo over weeks ...

Nearly 3.9 million people in England and Wales receive PIP - these are the health conditions most likely to receive ongoing payments ...

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

Abstract: This work proposes an innovative control approach for an isolated DC-DC converter tailored to DC grid applications. The architecture employs a cascaded choppers DCDC (CC DC-DC) topology, in ...

Bethen Thorpe, a PIP claimant who has relapsing MS, has successfully won against the Government three times at appeal tribunals. “Having to prove yourself over and over again makes you feel worthless, ...

DWP data shows which health conditions have the highest percentage of claimants receiving PIP awards of five years or longer ...

Foralumab nasal spray stabilized disability and eased fatigue in nonactive SPMS patients. It also prevented new lesions and reduced nervous system inflammation. A placebo-controlled Phase 2a trial is ...

Following acceptance for admission to UTSA, the process of obtaining services and accommodations through Student Disability Services starts with submitting an online application and documentation of a ...

Lower urinary tract symptoms (LUTS) remain one of the most prevalent and disabling clinical manifestations in multiple sclerosis (MS) patients, often emerging early in the disease course and ...

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its progression. Everyone who has MS has previously been infected with EBV, ...

Regular movement is one of the best tools you have to stay strong, steady, and independent when youre living with multiple sclerosis (MS). Physical activity of any kind as long as it can be performed ...